K. Gall

Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells

P. Sorensen, D. Busch, U. Dirksen, 2017, Oncoimmunology.

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy

W. Weichert, O. Witt, K. Specht, 2018, Oncotarget.

No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease

U. Dirksen, S. Burdach, T. Klingebiel, 2021, Bone Marrow Transplantation.